Moreover, ongoing studies target the identified genes (ENO1, STMN1, PKM, CDK1), with therapies like enolase 1 depletion demonstrating efficacy across various tumor types by inhibiting glycolysis, growth, proliferation, migration, metastasis, and sensitizing tumors to chemotherapy and radiotherapy [63]. This evidence concerns the gene PKM and neoplasm.